De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock.

MLA

Routsi, Christina, et al. “De-Escalation of Antimicrobial Therapy in ICU Settings with High Prevalence of Multidrug-Resistant Bacteria: A Multicentre Prospective Observational Cohort Study in Patients with Sepsis or Septic Shock.” The Journal of Antimicrobial Chemotherapy, vol. 75, no. 12, Dec. 2020, pp. 3665–74. EBSCOhost, https://doi.org/10.1093/jac/dkaa375.

APA

Routsi, C., Gkoufa, A., Arvaniti, K., Kokkoris, S., Tourtoglou, A., Theodorou, V., Vemvetsou, A., Kassianidis, G., Amerikanou, A., Paramythiotou, E., Potamianou, E., Ntorlis, K., Kanavou, A., Nakos, G., Hassou, E., Antoniadou, H., Karaiskos, I., Prekates, A., Armaganidis, A., … Giamarellou, H. (2020). De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. The Journal of Antimicrobial Chemotherapy, 75(12), 3665–3674. https://doi.org/10.1093/jac/dkaa375

Chicago

Routsi, Christina, Aikaterini Gkoufa, Kostoula Arvaniti, Stelios Kokkoris, Alexandros Tourtoglou, Vassiliki Theodorou, Anna Vemvetsou, et al. 2020. “De-Escalation of Antimicrobial Therapy in ICU Settings with High Prevalence of Multidrug-Resistant Bacteria: A Multicentre Prospective Observational Cohort Study in Patients with Sepsis or Septic Shock.” The Journal of Antimicrobial Chemotherapy 75 (12): 3665–74. doi:10.1093/jac/dkaa375.